Lucideon acquires second Dynamic Secondary Ion Mass Spectrometer

Lucideon is pleased to announce the acquisition of a second Dynamic Secondary Ion Mass Spectrometer (DSIMS).  The investment doubles the capacity for DSIMS analysis at Lucideon and represents a response to the demand for the service and Lucideon’s commitment to satisfying customer requirements.

DSIMS is a spectrometric technique that provides the elemental composition of a material’s surface and sub-surface to depths in excess of 100 microns.  The technique is important to a wide range of industries, such as healthcare, and can be used to identify contaminants, study structures and profile small surface areas.  The new state-of-the-art DSIMS instrument will allow Lucideon’s surface science experts to maintain their fast turnaround times and high levels of service for the increased demand.

Dr Alan Brown, Director of Development at Lucideon, said:

This is an important investment for Lucideon.  The new instrument has been bought in response to the increased demand we are seeing for our surface science services and the DSIMS technique in particular.

“Having the second instrument allows us to meet this demand without a drop in expected turnaround times for our clients, something that is very important to us as we pride ourselves on our exceptional delivery times.  It also demonstrates Lucideon’s commitment to continued growth as we continue to invest in the latest equipment and the right people to deliver the best service for our clients.”

DSIMS is part of a large suite of surface analysis techniques offered by Lucideon.  The surface science department works closely with all other areas of testing to provide an integrated and robust analytical service to its clients.  With expert experience spanning a wide range of industries the testing and analytical team at Lucideon provides valuable insight to a diverse client base, backed up with the latest state-of-the-art equipment.  Lucideon prides itself on its partnership approach to working with customers and delivering solutions, not just data.

To find out more about Lucideon’s testing and analysis services please visit www.lucideon.com/testing

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Lucideon. (2015, August 12). Lucideon acquires second Dynamic Secondary Ion Mass Spectrometer. News-Medical. Retrieved on April 27, 2024 from https://www.news-medical.net/news/20150812/Lucideon-acquires-second-Dynamic-Secondary-Ion-Mass-Spectrometer.aspx.

  • MLA

    Lucideon. "Lucideon acquires second Dynamic Secondary Ion Mass Spectrometer". News-Medical. 27 April 2024. <https://www.news-medical.net/news/20150812/Lucideon-acquires-second-Dynamic-Secondary-Ion-Mass-Spectrometer.aspx>.

  • Chicago

    Lucideon. "Lucideon acquires second Dynamic Secondary Ion Mass Spectrometer". News-Medical. https://www.news-medical.net/news/20150812/Lucideon-acquires-second-Dynamic-Secondary-Ion-Mass-Spectrometer.aspx. (accessed April 27, 2024).

  • Harvard

    Lucideon. 2015. Lucideon acquires second Dynamic Secondary Ion Mass Spectrometer. News-Medical, viewed 27 April 2024, https://www.news-medical.net/news/20150812/Lucideon-acquires-second-Dynamic-Secondary-Ion-Mass-Spectrometer.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Leader of materials technology development at Lucideon publishes third book on medical polymers